Pro-Pointer, Inc. Introduces a Revolutionary Supplement for Stress and Anxiety
August 24 2010 - 8:00AM
Marketwired
Pro-Pointer, Inc. (PINKSHEETS: PPII), through its wholly-owned
subsidiary Coenzyme-A Technologies, Inc., proudly announces today
the introduction of their latest Nutraceutical development, the
"MODULATOR MATRIX I" formula, especially designed to help the
individual user to effectively cope with today's Stress and Anxiety
Syndromes.
According to an American Psychological Association (APA) recent
study, a total of 43% of adults in the U.S. suffer adverse health
effects from stress. The National Institute of Mental Health
reports that Anxiety disorders affect approximately 40 million
American adults age 18 years or older. That clearly translates to
18% of the population in a given year. Stress is a psychological
response to an external happening, whereas anxiety is a state of
mind that is real or imagined and manifests itself in physical
symptoms like rapid heart rate and sweaty palms, sleeping disorders
and eventually depression.
Nickolaos D. Skouras, Ph.D., the President of Coenzyme-A
Technologies, Inc., explains that both stress and anxiety can cause
a cascade of biological reactions that occur in the brain. It is an
over stimulation of the Hypothalamic-Pituitary-Adrenal axis, which
over time can damage the immune system and cause a host of health
issues. Current studies also show that the metabolic enzyme
(Coenzyme-A) plays a major role in the body's ability to cope with
stress, anxiety, and depression and further strengthen the immune
system. During the process of combating stress and anxiety, the
human body secretes hormones as a means to adapt to the ever
increasing daily stress levels. These hormones are derivatives of
cholesterol and an increased demand for the synthesis of them by
the human body will prioritize and draw on the remaining available
Coenzyme-A pool, thus rendering a state of deficiency.
The market value of this revolutionary supplement for stress and
anxiety becomes readily apparent with the out-of-pocket costs and
undesirable side-effects of Anti-Depressant prescriptive medicine
skyrocketing, unemployment rates at all time highs and access to
affordable health care unavailable. Consumers are now turning to
preventative OTC solutions and remedies to stave off illness,
manage chronic injury and disease and promote overall health and
well-being. Market acceptance of natural products and herbal
dietary supplements is ever-growing as consumers pursue healthier,
eco-friendly lifestyles.
Coenzyme-A Technologies, Inc. has independently developed the
proprietary Coenzyme-A nutraceutical product "MODULATOR Matrix I"
that naturally addresses hormonal imbalances. Chemical imbalance
within the body and nutritional deficiencies that result from
Stress and Anxiety disorders and the deleterious effects of
Aging.
Based on the above facts, this latest Coenzyme-A development,
"Modulator Matrix I," and upon being properly marketed well,
represents annual gross sales of several million dollars.
ABOUT COENZYME-A TECHNOLOGIES, INC. -- Coenzyme-A Technologies,
Inc. is an innovative company that has applied new technology to
the formulation and manufacture of a series of proprietary products
which address nutritional deficiencies that result from the stress
of modern day living, chemical imbalances within the body, and the
effects of aging. Coenzyme-A is the first nutraceutical product to
combine nutritional components that can be successfully used by the
body to support its manufacture and utilization of cellular
Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific
set of substrates that are designed to assist the body in
converting fats, carbohydrates and proteins into energy at the
cellular level. See Company website -- www.coenzyme-a.com.
FORWARD-LOOKING STATEMENTS The information contained in this
news release, other than historical information, consists of
forward-looking statements within the meaning of Section 27A of the
Securities Act and Section 21E of the Exchange Act. These
statements may involve risks and uncertainties that could cause
actual results to differ materially from those described in such
statements. Such forward-looking statements involve known and
unknown risks and uncertainties, including all business
uncertainties relating to product development, marketing, market
acceptance, future capital requirements, competition in general and
other factors that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. The Company is under no obligation to (and
expressly disclaims any such obligation to) update or alter its
forward-looking statements whether as a result of new information,
future events or otherwise.
Contact Information: Pro-Pointer, Inc. 458 Coral Sea St.
Henderson, Nv. 89074 Ph- 702-458-4111 Cell-702-591-7440
Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart
From Nov 2024 to Dec 2024
Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart
From Dec 2023 to Dec 2024